New Delhi: The Union Government on December 07, 2021, informed the Rajya Sabha that it has formulated an action plan to standardization of Ayurvedic, Unani, Siddha, and Homoeopathy (Ayush) medicines in the country.
In a written reply in the Rajya Sabha, Minister of Ayush Sarbananda Sonowal said that the Government has established Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) under the Ministry of AYUSH.
The prime mandate of the Commission is to publish and revise Ayurvedic Pharmacopoeia of India (API), Siddha Pharmacopoeia of India (SPI), Unani Pharmacopoeia of India (UPI) and Homoeopathic Pharmacopoeia of India (HPI), he said.
“The Pharmacopoeial standards are basic need to ensure quality, safety and efficacy of Ayurvedic, Siddha, Unani and Homoeopathic medicines. The Pharmacopoeia Commission is also responsible to publish and revise Ayurvedic, Siddha and Unani official formularies and regulatory compendiums. These published standards become part of Drugs and Cosmetics Act, 1940 and Rules, 1945 for ascertaining the quality standards of Raw materials/drugs and implemented uniformly across India.”
The Minister further added that it is mandatory for the manufacturer of ASU&H drugs to obtain a licence from the concerned State Licensing Authority (SLA) and comply with the prescribed Good Manufacturing Practices (GMP) and quality standards of drugs given in the respective Pharmacopoeias.
“The SLA grants the licence after verification of the required infrastructural facilities, equipment/machinery, manpower of the manufacturing unit through inspection(s) conducted by the inspector.”
The Government has also set up separate Central Research Councils for undertaking, promoting, coordinating research and scientific validation of Ayurvedic, Unani, Siddha and Homoeopathic medicines.
“So far Government has published Ayurvedic Formulary of India (Part I-III) containing 986 Formulations, Siddha Formulary of India (Part I-II) containing 400 Formulations and National Formulary of Unani Medicine (Vol. I-VI) containing 1230 Formulations. Monographs of quality standards of 645 Single drugs and 203 Formulations of Ayurveda; 139 Single drugs and 1 Formulation of Siddha; 298 Single drugs and 201 Formulations of Unani; and 1117 drugs of Homoeopathy (Vol. I-X).”
Sonowal also informed that the Central Council for Research in Homoeopathy (CCRH) has filed 8 patents and the Central Council for Research in Ayurvedic Sciences (CCRAS) has obtained one patent, the Central Council for Research in Siddha (CCRS) has processed for patent of 10 products during last five years. (Press Release)